1.
J Eur Acad Dermatol Venereol
; 36(10): e806-e808, 2022 10.
Artículo
en Inglés
| MEDLINE
| ID: mdl-35648446
2.
Actas Dermosifiliogr (Engl Ed)
; 110(7): 526-532, 2019 Sep.
Artículo
en Inglés, Español
| MEDLINE
| ID: mdl-30975431
RESUMEN
Osler-Weber-Rendu syndrome, also known as hereditary hemorrhagic telangiectasia, is a rare autosomal dominant disorder with an estimated worldwide prevalence of 1 case per 10,000 population. Its clinical manifestations are the result of arteriovenous malformations characterized by telangiectases that can affect the skin, mucous membranes, and solid organs and cause life-threatening conditions, such as liver disease, systemic emboli, and heart failure. Timely diagnosis is thus essential in order to prevent disease-related complications and offer genetic counseling to families. We review the clinical features of Osler-Weber-Rendu syndrome with a focus on mucocutaneous manifestations and their treatment.